Momenta Pharmaceuticals Spikes Up Following FDA News On Copaxone By: Benzinga via Benzinga April 16, 2015 at 14:54 PM EDT Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) fell nearly 4 percent Thursday to $63.34 following news that the FDA denied its ... Read More >> Related Stocks: Momenta Pharma Mylan Teva Pharmaceutical Industries ADR